HRAS, NRAS, and KRAS, collectively referred to as oncogenic RAS, are the most frequently mutated driver proto‐oncogenes in cancer; the relationship between oncogenic RAS and ferroptosis is still controversial [43]. This evidence concerns the gene HRAS and cancer.